Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

docetaxel

Trial Locations (13)

08816

Central Jersey Oncology Center, PA - East Brunswick, East Brunswick

08818

JFK Medical Center in Edison, Edison

07728

CentraState Medical Center, Freehold

08690

Cancer Institute of New Jersey at Hamilton, Hamilton

07740

Monmouth Medical Center, Long Branch

07042

Mountainside Hospital Cancer Center, Montclair

07754

Jersey Shore University Medical Center, Neptune City

08903

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick

Saint Peter's University Hospital, New Brunswick

07103

UMDNJ - University Hospital, Newark

08861

Raritan Bay Medical Center, Perth Amboy

08876

Somerset Medical Center, Somerville

07901

Overlook Hospital, Summit

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

University of Medicine and Dentistry of New Jersey

OTHER